Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Knowing when to start retirement planning is crucial for a secure future. Gain insights that will help you prepare effectively for retirement.
15,993 articlesUBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
The Iran-backed Houthis say they fired on Israel, marking their first missile strike in the current conflict. Israel ...
European defense funding is moving to multi-year commitments, reshaping orders for European and U.S. defense contract...
AI growth stocks may ride the wave of innovation, but a stubborn helium shortage could cap upside. Even if Iran ends,...
Griffon (GFF) 2026 earnings season offers clues about growth and margins across its portfolio. This guide breaks down...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
As Stanford’s AI Index shows lagging adoption in the U.S., analysts say the real payoff comes from integration and tr...
What really moved Si-Bone in Q1 2026? Our practical analysis breaks down revenue trends, margins, and the company’s a...
Rising internal strife and political pressure push the FDA toward leadership change, with markets watching how the ag...
A practical, down-to-earth look at Howmet’s 2026 earnings outlook. This guide breaks down drivers, risks, and actiona...